Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The bleeding rate of both EGD (including biopsy) and colonoscopy (including biopsy, cold or hot snare polypectomy, or EMR) in patients who continue to take various antithrombotic drugs is studied prospectively. The immediate or delayed bleeding that requires hemostatic clipping or other endoscopic treatments is defined as the bleeding. Immediate bleeding requiring hemostatic clipping is defined as spurting or oozing which continued for more than 30 seconds. Delayed bleeding is defined as bleeding that requires the endoscopic treatment within 2 weeks after endoscopy. Prophylactic clipping is not performed after taking biopsy and doing polypectomy. Additionally, investigators evaluate the rate of injured submucosal arteries of the excised specimen when the bleeding occurs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 90
Healthy Volunteers: f
View:

• Inclusion criteria is all patients who continue to take antithrombotic drugs and undergo EGD or colonoscopy

Locations
Other Locations
Japan
Showa Inan General Hospital
RECRUITING
Komagane
Contact Information
Primary
Akira Horiuchi, MD
horiuchi.akira@sihp.jp
0265822121
Time Frame
Start Date: 2015-11
Estimated Completion Date: 2026-12
Participants
Target number of participants: 10000
Related Therapeutic Areas
Sponsors
Leads: Showa Inan General Hospital

This content was sourced from clinicaltrials.gov